For optimal 1-year results, in patients with prior coronary artery bypass grafting who need percutaneous coronary ...
After percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) is recommended for 6 months in stable coronary artery disease1,2 and 12 months in acute coronary syndromes.3,4 Over the ...
In patients with unprotected left main stenosis, there was no difference in all-cause mortality at 10 years between patients who had percutaneous coronary intervention and those who underwent coronary ...
A surprising number of patients undergoing coronary artery bypass graft (CABG) surgery will require postprocedure coronary angiography and emergent percutaneous coronary intervention (PCI) before ...
New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates ...
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...
LithiX™ HC-IVL is a novel lithotripsy system designed to facilitate treatment of heart disease exacerbated by the presence of calcium within ...
For certain patients presenting at hospitals with a heart attack, or myocardial infarction, clinicians may choose to conduct percutaneous coronary intervention (PCI), a minimally invasive procedure to ...
The single-arm INVEST-CTO study showed high procedural success with a two-part intervention, but questions remain.
New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback